Jane Street’s Intersect ENT, Inc XENT Stock Holding History

Jane Street’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-17,578	Closed	-$208K	–	7739
2020 Q1	$208K	Buy	17,578 +7,178	+69%	+$159K	﹤0.01%	4617
2019 Q4	$259K	Buy	+10,400	New	+$211K	﹤0.01%	4460

Other funds holding XENT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jane Street's XENT Position: Q2 2020 in Review

Jane Street sold out of Intersect ENT, Inc (XENT) in Q2 2020, closing a stake of 17,578 shares — an estimated $208K sold.

Jane Street first reported a position in XENT in Q4 2019 and held it in 2 quarters. The position peaked at $259K in Q4 2019. 108 funds tracked by Wall St. Rank hold XENT as of Q2 2020.

Jane Street reported no remaining Intersect ENT, Inc position as of Q2 2020 after selling out during the quarter.
Jane Street sold 17,578 Intersect ENT, Inc shares in Q2 2020, an estimated $208K.
Jane Street first reported a position in Intersect ENT, Inc in Q4 2019 and held it in 2 quarters.
Jane Street's Intersect ENT, Inc position peaked at $259K in Q4 2019.
108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2020.

Based on Jane Street's 13F filing for Q2 2020, filed 17 Aug 2020.